Zydus Cadila gets USFDA’s final nod for Triamterene, Hydrochlorothiazide Capsules
Zydus Cadila has received the final approval from the United States Food and Drug Administration (USFDA) to market Triamterene and Hydrochlorothiazide Capsules USP (US RLD-DYAZIDE),…